Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/29/2010WO2010150791A1 Process for production of adenosine tetraphosphate compound
12/29/2010WO2010150761A1 Pyridine derivative having ((phosphonooxy)methyl)pyridinium ring and anti-fungal agent comprising same
12/29/2010WO2010150739A1 Hydroxyl-containing pyripyropene derivatives exhibiting acat2-inhibitory activity
12/29/2010WO2010150612A1 Hyaluronic acid production promoter and melanin production inhibitor
12/29/2010WO2010150564A1 Benzaldehyde compound
12/29/2010WO2010150538A1 Drug for inhibiting lectin-like oxidized ldl receptor and drug for preventing arteriosclerosis
12/29/2010WO2010150525A1 Urate transporter, as well as method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug
12/29/2010WO2010150400A1 Jelly preparation containing isosorbide
12/29/2010WO2010150378A1 Ophthalmic composition
12/29/2010WO2010150281A2 Novel azabicyclohexanes
12/29/2010WO2010150280A1 Disubstituted benzamide derivatives as glucokinase (gk) activators
12/29/2010WO2010150279A2 Process for synthesis of diarylpyrimidine non-nucleoside reverse transcriptase inhibitor
12/29/2010WO2010150271A1 Process for obtaining purified pterostilbene and methods of use thereof
12/29/2010WO2010150261A1 A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
12/29/2010WO2010150231A1 Antisense oligonucleotides capable of inducing exon skipping and the use thereof as a medicament for the treatment of duchenne muscular dystrophy (dmd)
12/29/2010WO2010150221A1 Taste masked pharmaceutical compositions of pregabalin
12/29/2010WO2010150219A1 Pharmaceutical composition of duloxetine or pharmaceutically acceptable salts thereof
12/29/2010WO2010150211A2 Use of derivatives of indoles for the treatment of cancer
12/29/2010WO2010150206A1 N-substituted-n-phenylethylsulfonamides for the identification of biological and pharmacological activity
12/29/2010WO2010150192A1 Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
12/29/2010WO2010150127A1 Glucosamine formulations
12/29/2010WO2010150100A1 The use of spinosyns and spinosyn compositions against diseases caused by protozoans, viral infections and cancer
12/29/2010WO2010150098A2 Treatment of endometriosis
12/29/2010WO2010150079A1 Combined use of creatine phosphate and creatine phosphokinase for treatment of arteriosclerosis
12/29/2010WO2010150072A1 Synergistic combination to enhance blood glucose and insulin metabolism
12/29/2010WO2010150036A1 Sol-gel nanostructured and biocompatible platinum-titania and platinum- silica biocatalysts nanostructured and biocompatible for use in cancer treatment
12/29/2010WO2010150014A1 5r- 5 -deuterated glitazones for respiratory disease treatment
12/29/2010WO2010149968A1 3-substituted-8-substituted-3h imidazo[5,1-d][1,2,3,5-tetrazin-4-one compounds and their use
12/29/2010WO2010149944A1 Indolyl-substituted pyrazino-quinolines and their use for the treatment of cancer
12/29/2010WO2010149943A1 New compounds and medical use
12/29/2010WO2010149888A1 Derivatives of 2-mercaptocyclopentane carboxylic acid, method for the preparation thereof, and pharmaceutical compositions containing the same
12/29/2010WO2010149821A1 N-substituted n-phenethyl sulfonamide libraries for drug discovery
12/29/2010WO2010149820A1 N-phenyl-1-sulfonyl-2-pyrrolidine carboxamide libraries for drug discovery
12/29/2010WO2010149819A1 N-(1-phenyl-2-oxo-3-piperidyl sulphonamide libraries for drug discovery
12/29/2010WO2010149817A1 Dioxanes derived from regrouping carbohydrates and c-glycosides, method for obtaining same, and uses thereof
12/29/2010WO2010149815A1 Olive-oil-based functional oils
12/29/2010WO2010149794A2 Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane)
12/29/2010WO2010149786A1 Pyrido [2, 3-d] pyrimidines as wnt antagonists for treatment of cancer and arthritis
12/29/2010WO2010149783A1 Tricyclic pyrimidine derivatives as wnt antagonists
12/29/2010WO2010149772A1 Preparation comprising insulin, nicotinamide and an amino acid
12/29/2010WO2010149771A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
12/29/2010WO2010149769A1 5-phenyl-[1,2,4 ]triazolo[1,5-a]pyridin-2-yl carboxamides as jak inhibitors
12/29/2010WO2010149761A1 Composition for treatment of tuberculosis
12/29/2010WO2010149759A1 Microparticles comprising a fat soluble fraction comprising dha and their production
12/29/2010WO2010149758A1 Antifungal 1, 2, 4-triazolyl derivatives
12/29/2010WO2010149755A1 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17
12/29/2010WO2010149685A1 New compounds, pharmaceutical composition and methods relating thereto
12/29/2010WO2010149684A1 New compounds, pharmaceutical composition and methods relating thereto
12/29/2010WO2010149666A1 Methods for treating neoplasia
12/29/2010WO2010149658A2 Pharmaceutical composition of gamma-butyrobetaine or a pharmaceutically acceptable salt and meldonium or a pharmaceutically acceptable salt
12/29/2010WO2010149654A1 Pharmaceutical composition of gamma-butyrobetaine or a pharmaceutically acceptable salt and meldonium or a pharmaceutically acceptable salt
12/29/2010WO2010149653A1 A pharmaceutical composition comprising meldonium succinate and medical uses thereof
12/29/2010WO2010149634A1 Novel indole, indazole and benzimidazole arylamides as p2x3 and/or p2x2/3 antagonists
12/29/2010WO2010149541A1 Novel oxazolone and pyrrolidinone-substituted arylamides
12/29/2010WO2010149414A1 5-mercapto-[1, 2, 4] triazolylmethyl-cyclopentanol compounds and their agricultural and pharmaceutical uses
12/29/2010WO2010149394A1 Combination treatment op a g2 checkpoint inhibitor (sb-218078) and a chemotherapeutic agent for tumorigenic cells in solid tumors
12/29/2010WO2010149363A2 A pharmaceutical composition
12/29/2010WO2010149329A1 Applicator for applying a product to hair
12/29/2010WO2010149326A1 Acid-labile trigger units
12/29/2010WO2010149273A1 Pharmaceutical composition for emergency contraception
12/29/2010WO2010149257A1 Alkoxy-thienopyrimidines as tgf-beta receptor kinase modulators
12/29/2010WO2010149230A1 Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane) hydrochloride
12/29/2010WO2010149215A1 Artesunate pharmaceutical compositions soluble in aqueous solutions
12/29/2010WO2010149196A1 Taste masked dosage form of pharmaceutically acceptable salt of escitalopram
12/29/2010WO2010149183A1 Aprepitant in the form of a solid solution
12/29/2010WO2010149170A1 Treatment of insulin resistance and obesity by stimulating glp-1 release
12/29/2010WO2010149044A1 Micromolecular benzotriazine compounds, compositions and uses thereof
12/29/2010WO2010148963A1 Compounds having activity against hepatitis virus and use thereof
12/29/2010WO2010148653A1 Polymer vesicles of asymmetric membrane
12/29/2010WO2010148650A1 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
12/29/2010WO2010148649A1 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
12/29/2010WO2010148632A1 Dihydropyridine compounds and preparation methods, pharmaceutical compositions and uses thereof
12/29/2010WO2010148631A1 Dihydropyrimidine compounds and preparation methods, pharmaceutical compositions and uses thereof
12/29/2010WO2010148519A1 Methods and therapies for alleviating pain comprising an ultra low dose of an alpha 2 receptor antagonist
12/29/2010WO2010148488A1 Cathepsin cysteine protease inhibitors for the treatment of various diseases
12/29/2010WO2010148422A1 Compounds and methods for treating parasitic infestations
12/29/2010WO2010132670A3 Pentacycline compounds
12/29/2010WO2010131032A3 Novel polymers
12/29/2010WO2010129848A3 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxamides
12/29/2010WO2010129242A3 Treatment of osteoarthritis pain
12/29/2010WO2010127246A3 Hnf4 modulators and methods of use
12/29/2010WO2010127100A8 Compositions comprising an antihistamine, antitussive and decongestant in extended release formulations
12/29/2010WO2010122578A3 Process for preparation of sitagliptin and its intermediates
12/29/2010WO2010122474A3 A medicinal antifungal and steroid cream incorporating a biopolymer and a process to make it
12/29/2010WO2010122473A3 A medicinal antifungal and steroid cream incorporating a biopolymer and a process to make it
12/29/2010WO2010118866A8 Trehalulose-containing composition, its preparation and use
12/29/2010WO2010113183A3 Process for the preparation of 1-[[[3-[2-(dimethylamino)ethyl]-1h-indol-5-yl]methyl]sulfonyl] pyrrolidine and its pharmaceutically acceptable salts
12/29/2010WO2010101353A9 Composition containing human serum albumin-timp-2 fusion protein and anti-cancer drug for preventing or treating cancer
12/29/2010WO2010091649A4 A composition for buccal absorption of nicotine for the purpose of smoking cessation
12/29/2010WO2010091052A3 Methods for enhancing hematopoietic stem/progenitor cell engraftment
12/29/2010WO2010088564A3 Compositions and methods for the treatment of cancer
12/29/2010WO2010088222A3 A high molecular weight polysaccharide that binds and inhibits virus
12/29/2010WO2010079433A3 Pharmaceutical composition comprising melogliptin
12/29/2010WO2010079406A9 Compounds and uses thereof for treating inflammation and modulating immune responses
12/29/2010WO2010078883A3 Combined disinfection and decontamination agent having increased effectivity
12/29/2010WO2010078730A9 Preparation of ginsenoside-rd propylene glycol aqueous solution and new use thereof in anti-inflammation, immunosuppression and anti organ-graft rejection
12/29/2010WO2010063996A3 Antibacterial compounds
12/29/2010WO2009156071A8 Combination of amidine derivates with cyclic depsipeptides
12/29/2010WO2009153305A3 Pharmaceutical compositions of montelukast sodium
12/29/2010WO2009137900A3 Stabilization processes of cation radicals of phenothiazinic compounds, cosmeceutical formulations and methods for skin diseases and disturbances prevention
1 ... 1934 1935 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 ... 7860